LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$42.5

Market cap

$2.28B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.61

Enterprise value

$2.33B

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through ...

Highlights
LivaNova's EPS has increased by 40% YoY and by 4.7% QoQ
The net income is up by 36% YoY and by 7% from the previous quarter
The equity has declined by 7% year-on-year but it rose by 5% since the previous quarter
LIVN's debt has soared by 107% year-on-year
LivaNova's gross margin has decreased by 2.9% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: NVRO OFIX NUVA

Key stats

What are the main financial stats of LIVN
Market
Shares outstanding
53.56M
Market cap
$2.28B
Enterprise value
$2.33B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.88
Price to sales (P/S)
2.22
EV/EBIT
N/A
EV/EBITDA
75.59
EV/Sales
2.28
Earnings
Revenue
$1.02B
EBIT
-$26.95M
EBITDA
$30.85M
Free cash flow
$43.4M
Per share
EPS
-$1.61
Free cash flow per share
$0.81
Book value per share
$22.56
Revenue per share
$19.11
TBVPS
$21.65
Balance sheet
Total assets
$2.29B
Total liabilities
$1.09B
Debt
$571.05M
Equity
$1.21B
Working capital
$588.74M
Liquidity
Debt to equity
0.47
Current ratio
2.98
Quick ratio
2.35
Net debt/EBITDA
1.8
Margins
EBITDA margin
3%
Gross margin
69.2%
Net margin
-8.4%
Operating margin
-7.5%
Efficiency
Return on assets
-3.7%
Return on equity
-7%
Return on invested capital
-3%
Return on capital employed
-1.3%
Return on sales
-2.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
1.92%
1 week
-2.55%
1 month
-11.44%
1 year
-45.69%
YTD
-23.48%
QTD
-23.48%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.02B
Gross profit
$707.23M
Operating income
-$76.75M
Net income
-$86.25M
Gross margin
69.2%
Net margin
-8.4%
LIVN's net margin is up by 36% year-on-year and by 8% since the previous quarter
The net income is up by 36% YoY and by 7% from the previous quarter
The company's operating income fell by 16% QoQ
LivaNova's operating margin has decreased by 15% QoQ

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
P/E
N/A
P/B
1.88
P/S
2.22
EV/EBIT
N/A
EV/EBITDA
75.59
EV/Sales
2.28
LivaNova's EPS has increased by 40% YoY and by 4.7% QoQ
The price to book (P/B) is 30% lower than the 5-year quarterly average of 2.7 and 30% lower than the last 4 quarters average of 2.7
The equity has declined by 7% year-on-year but it rose by 5% since the previous quarter
The price to sales (P/S) is 38% lower than the 5-year quarterly average of 3.6 and 33% lower than the last 4 quarters average of 3.3

Efficiency

How efficient is LivaNova business performance
The ROIC has soared by 75% YoY and by 49% from the previous quarter
LivaNova's return on sales has surged by 64% YoY and by 38% QoQ
The return on equity has grown by 39% year-on-year and by 5% since the previous quarter
The company's return on assets rose by 37% YoY and by 10% QoQ

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 111% higher than its total liabilities
LivaNova's total liabilities has increased by 20% YoY
The company's total assets rose by 4.3% YoY and by 3.7% QoQ
LIVN's debt is 53% smaller than its equity
LIVN's debt to equity has surged by 124% year-on-year but it is down by 6% since the previous quarter
LIVN's debt has soared by 107% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.